Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications
Joseph F. Malouf, MD, FACC*,*,
Maurice Enriquez-Sarano, MD, FACC*,
Patricia A. Pellikka, MD, FACC*,
Jae K. Oh, MD, FACC*,
Kent R. Bailey, PhD ,
Krishnaswamy Chandrasekaran, MD, FACC*,
Charles J. Mullany, MD, FACC and
A. Jamil Tajik, MD, FACC*
* Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
Section of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA
Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA

View larger version (14K):
[in a new window]
|
Figure 1 Kaplan-Meier survival curves for aortic valve replacement patients in the study (solid lines A and B) compared with expected survival of U.S. white population (dotted lines in A and B). (A) Operative mortality included. (B) Operative mortality not included.
|
|

View larger version (14K):
[in a new window]
|
Figure 2 Kaplan-Meier survival curves for patients in the study (solid lines in A and B) compared with expected survival of U.S. white population (dotted lines in A and B). (A) All patients with severe aortic valve stenosis and severe pulmonary hypertension. (B) Patients treated conservatively without aortic valve replacement (no aortic valve replacement group).
|
|
|